StemCells (STEM) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts STEM Hot Sheet
Price: $4.55 -3.6%
EPS Growth %: +44.0%
Financial Fact:
Interest expense: -128
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +44.0%
Financial Fact:
Interest expense: -128
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
StemCells (NASDAQ: STEM) reported Q3 EPS of ($0.14), $0.02 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $883 million versus the consensus estimate of $220 million.
For earnings history and earnings-related data on StemCells (STEM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Lucid Capital Markets Starts Bain Capital Specialty Finance (BCSF) at Neutral
- B.Riley Assumes Anika Therapeutics (ANIK) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
